Pfizer's Lipitor Cuts Risk of Repeat Stroke by 16% (Update1) -
May 17 (Bloomberg) -- Pfizer Inc., the world's biggest drugmaker, may increase sales of its Lipitor cholesterol drug after a study showed the medicine reduced the risk of repeat strokes in a new set of patients.
Lipitor reduced the risk in people who don't have a history of heart disease by 16 percent, researchers said today at the European Stroke Conference in Brussels. The product, also known by its generic name atorvastatin, was the world's best-selling drug with $12.2 billion in revenue in 2005.
· Read The Full Lipitor Article From Bloomberg -->
·
Read All Lipitor (Atorvastatin) News Stories -->